Gabapentin (Neurontin)
Gabapentin risk profile, scheduling, and guidance for claims professionals and care workers . Also known as Neurontin, Nupentin 300, Gabapentin Sandoz, Gabacor, GAPENTIN and 8 more.
Gabapentin (brand names: Neurontin, Nupentin 300, Gabapentin Sandoz, Gabacor, GAPENTIN and 8 more) is classified as Moderate risk (3 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Gabapentinoid with CNS depression risk and potential for abuse when combined with opioids.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Moderate (3 points)
- CNS depressant: May cause sedation, impair driving, and affect work capacity
- Respiratory depression risk: Requires monitoring, especially with other CNS depressants
- Recommended maximum duration: 90 days
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | PBS listed |
Risk Profile
Gabapentinoid with CNS depression risk and potential for abuse when combined with opioids.
Regulatory and Compliance Guidance
When Gabapentin appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Work capacity impact: As a CNS depressant, Gabapentin may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
United Kingdom NICE / MHRA / FPM
NICE CG173 (Neuropathic Pain) includes pregabalin and gabapentin as treatment options for neuropathic pain. The MHRA has issued safety warnings about gabapentinoid misuse and respiratory depression risk when combined with opioids.
UK drug driving laws (Section 5A Road Traffic Act 2006) set specific limits for prescription drugs that cause impairment. Employers and occupational health advisors should assess fitness to work.
Need to assess this medication across your caseload?
Run a full risk assessment including Gabapentin interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
Book a DemoFree trial available. No credit card required.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.